539 related articles for article (PubMed ID: 1918378)
1. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
[TBL] [Abstract][Full Text] [Related]
2. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
3. Glucose-fatty acid cycle operates in humans at the levels of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations.
Vaag AA; Handberg A; Skøtt P; Richter EA; Beck-Nielsen H
Eur J Endocrinol; 1994 Jan; 130(1):70-9. PubMed ID: 8124481
[TBL] [Abstract][Full Text] [Related]
4. Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.
Suh KI; Murata C; Song YM; Joyce M; Gumbiner B; Ditzler TM; Henry RR
J Clin Endocrinol Metab; 1993 Aug; 77(2):464-70. PubMed ID: 8345053
[TBL] [Abstract][Full Text] [Related]
5. Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.
Mandarino LJ; Consoli A; Kelley DE; Reilly JJ; Nurjhan N
J Clin Endocrinol Metab; 1990 Dec; 71(6):1544-51. PubMed ID: 2121778
[TBL] [Abstract][Full Text] [Related]
6. Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin.
Riccio A; Del Prato S; Vigili de Kreutzenberg S; Tiengo A
Diabete Metab; 1991 May; 17(1 Pt 2):180-4. PubMed ID: 1936473
[TBL] [Abstract][Full Text] [Related]
7. Relationship between insulin-mediated glucose disposal and lipid metabolism in man.
Lillioja S; Bogardus C; Mott DM; Kennedy AL; Knowler WC; Howard BV
J Clin Invest; 1985 Apr; 75(4):1106-15. PubMed ID: 3886702
[TBL] [Abstract][Full Text] [Related]
8. Effects of fatty acids on exercise plus insulin-induced glucose utilization in trained and sedentary subjects.
Matzinger O; Schneiter P; Tappy L
Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E125-31. PubMed ID: 11739092
[TBL] [Abstract][Full Text] [Related]
9. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
[TBL] [Abstract][Full Text] [Related]
10. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.
Worm D; Henriksen JE; Vaag A; Thye-Rønn P; Melander A; Beck-Nielsen H
J Clin Endocrinol Metab; 1994 Mar; 78(3):717-21. PubMed ID: 8126147
[TBL] [Abstract][Full Text] [Related]
11. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
[TBL] [Abstract][Full Text] [Related]
12. Reduction of plasma NEFA concentration by nicotinic acid enhances the response to insulin in feed-restricted Holstein cows.
Pires JA; Pescara JB; Grummer RR
J Dairy Sci; 2007 Oct; 90(10):4635-42. PubMed ID: 17881684
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.
Fulcher GR; Walker M; Catalano C; Agius L; Alberti KG
Diabetes; 1992 Nov; 41(11):1400-8. PubMed ID: 1397716
[TBL] [Abstract][Full Text] [Related]
14. Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate.
Fulcher GR; Walker M; Farrer M; Johnson AS; Alberti KG
Metabolism; 1993 Mar; 42(3):308-14. PubMed ID: 8487648
[TBL] [Abstract][Full Text] [Related]
15. Interaction of lipid and carbohydrate metabolism after infusions of lipids or of lipid lowering agents: lack of a direct relationship between free fatty acid concentrations and glucose disposal.
Kleiber H; Munger R; Jallut D; Tappy L; Felley C; Golay A; Frascarolo P; Jéquier E; Felber JP
Diabete Metab; 1992; 18(2):84-90. PubMed ID: 1511757
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.
Del Prato S; Bonadonna RC; Bonora E; Gulli G; Solini A; Shank M; DeFronzo RA
J Clin Invest; 1993 Feb; 91(2):484-94. PubMed ID: 8432857
[TBL] [Abstract][Full Text] [Related]
17. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women.
Bonora E; Del Prato S; Bonadonna RC; Gulli G; Solini A; Shank ML; Ghiatas AA; Lancaster JL; Kilcoyne RF; Alyassin AM
Diabetes; 1992 Sep; 41(9):1151-9. PubMed ID: 1499866
[TBL] [Abstract][Full Text] [Related]
18. Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients.
Piatti PM; Monti LD; Davis SN; Conti M; Brown MD; Pozza G; Alberti KG
Diabetologia; 1996 Jan; 39(1):103-12. PubMed ID: 8720610
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM.
Diraison F; Large V; Brunengraber H; Beylot M
Diabetologia; 1998 Feb; 41(2):212-20. PubMed ID: 9498656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]